Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127234) titled 'Pharmacogenomics-Based Screening of SGLT-2 Receptor Genes' on June 26.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First People's Hospital of Guiyang
Condition:
Type 2 Diabetes Mellitus
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-30
Target Sample Size: Type 2 diabetes observation group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=326953
Published by HT Digital Content Services with permission from Health Daily Digest....